Controlled reoxygenation cardiopulmonary bypass is associated with reduced transcriptomic changes in cyanotic tetralogy of Fallot patients undergoing surgery

Physiological Genomics

Volumn 44, Issue 22, 2012, Pages 1098-1106

  Ghorbel, Mohamed T ^a   Mokhtari, Amir ^a   Sheikh, Maimuna ^a   Angelini, Gianni D ^a   Caputo, Massimo ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

Congenital heart disease; Gene expression; Hypoxia; Reoxygenation injury; Surgery

Indexed keywords

CARRIER PROTEIN; CRIP3 PROTEIN; MOSC1 PROTEIN; PDE1A PROTEIN; PROTEIN; SCLEROPROTEIN; TRANSCRIPTOME; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; CARDIOPULMONARY BYPASS; CELL ADHESION; CELL METABOLISM; CLINICAL ARTICLE; CONTROLLED REOXYGENATION; CYANOSIS; DOWN REGULATION; EXTRACELLULAR MATRIX; FALLOT TETRALOGY; GENE EXPRESSION PROFILING; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; HYPEROXIA; INFANT; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REOXYGENATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; UPREGULATION;

ANOXIA; CARDIOPULMONARY BYPASS; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 1; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; MALE; MYOCARDIUM; OXYGEN; REAL-TIME POLYMERASE CHAIN REACTION; TETRALOGY OF FALLOT;

EID: 84873251735     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00072.2012     Document Type: Article

References (39)

1. Allen BS, Rahman S, Ilbawi MN, Kronon M, Bolling KS, Halldorsson AO, Feinberg H. Detrimental effects of cardiopulmonary bypass in cyanotic infants: preventing the reoxygenation injury. Ann Thorac Surg 64: 1381-1387, 1997.
2. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29, 2000.
3. Blasig IE, Grune T, Schonheit K, Rohde E, Jakstadt M, Haseloff RF, Siems WG. 4-Hydroxynonenal, a novel indicator of lipid peroxidation for reperfusion injury of the myocardium. Am J Physiol Heart Circ Physiol 269: H14-H22, 1995.
4. Bulutcu FS, Bayindir O, Polat B, Yalcin Y, oZbek U, Cakali E. Does normoxemic cardiopulmonary bypass prevent myocardial reoxygenation injury in cyanotic children? J Cardiothorac Vasc Anesth 16: 330-333, 2002.
5. Caputo M, Mokhtari A, Rogers CA, Panayiotou N, Chen Q, Ghorbel MT, Angelini GD, Parry AJ. The effects of normoxic versus hyperoxic cardiopulmonary bypass on oxidative stress and inflammatory response in cyanotic pediatric patients undergoing open cardiac surgery: a randomized controlled trial. J Thorac Cardiovasc Surg 138: 206-214, 2009.
6. Chi NC, Karliner JS. Molecular determinants of responses to myocardial ischemia/reperfusion injury: focus on hypoxia-inducible and heat shock factors. Cardiovasc Res 61: 437-447, 2004.
7. Cope LM, Irizarry RA, Jaffee HA, Wu Z, Speed TP. A benchmark for Affymetrix GeneChip expression measures. Bioinformatics 20: 323-331, 2004.
8. del Nido PJ, Mickle DA, Wilson GJ, Benson LN, Coles JG, Trusler GA, Williams WG. Evidence of myocardial free radical injury during elective repair of tetralogy of Fallot. Circulation 76: V174-V179, 1987.
9. del Nido PJ, Mickle DA, Wilson GJ, Benson LN, Weisel RD, Coles JG, Trusler GA, Williams WG. Inadequate myocardial protection with cold cardioplegic arrest during repair of tetralogy of Fallot. J Thorac Cardiovasc Surg 95: 223-229, 1988.
10. Delanty N, Reilly MP, Pratico D, Lawson JA, McCarthy JF, Wood AE, Ohnishi ST, Fitzgerald DJ, FitzGerald GA. 8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation 95: 2492-2499, 1997.
11. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3, 2003.
12. Dhaliwal H, Kirshenbaum LA, Randhawa AK, Singal PK. Correlation between antioxidant changes during hypoxia and recovery on reoxygenation. Am J Physiol Heart Circ Physiol 261: H632-H638, 1991.
13. Freeman BA, Topolosky MK, Crapo JD. Hyperoxia increases oxygen radical production in rat lung homogenates. Arch Biochem Biophys 216: 477-484, 1982.
14. Garattini E, Mendel R, Romao MJ, Wright R, Terao M. Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology. Biochem J 372: 15-32, 2003.
15. Ghorbel MT, Cherif M, Jenkins E, Mokhtari A, Kenny D, Angelini GD, Caputo M. Transcriptomic analysis of patients with tetralogy of Fallot reveals the effect of chronic hypoxia on myocardial gene expression. J Thorac Cardiovasc Surg 140: 337-345, 2010.
16. Hearse DJ, Humphrey SM, Chain EB. Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol 5: 395-407, 1973.
17. Ihnken K, Morita K, Buckberg GD. Delayed cardioplegic reoxygenation reduces reoxygenation injury in cyanotic immature hearts. Ann Thorac Surg 66: 177-182, 1998.
18. Ihnken K, Morita K, Buckberg GD, Matheis G, Sherman MP, Allen BS, Young HH. Studies of hypoxemic/reoxygenation injury: without aortic clamping. II. Evidence for reoxygenation damage. J Thorac Cardiovasc Surg 110: 1171-1181, 1995.
19. Ihnken K, Morita K, Buckberg GD, Sherman MP, Young HH. Studies of hypoxemic/reoxygenation injury: without aortic clamping. III. Comparison of the magnitude of damage by hypoxemia/reoxygenation versus ischemia/reperfusion. J Thorac Cardiovasc Surg 110: 1182-1189, 1995.
20. Ihnken K, Winkler A, Schlensak C, Sarai K, Neidhart G, Unkelbach U, Mulsch A, Sewell A. Normoxic cardiopulmonary bypass reduces oxidative myocardial damage and nitric oxide during cardiac operations in the adult. J Thorac Cardiovasc Surg 116: 327-334, 1998.
21. Imura H, Caputo M, Parry A, Pawade A, Angelini GD, Suleiman MS. Age-dependent and hypoxia-related differences in myocardial protection during pediatric open heart surgery. Circulation 103: 1551-1556, 2001.
22. Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T, Ueki K, Yoshiyama M, Ikawa M, Okabe M, Schaffer SW, Fujio Y, Azuma J. Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J Mol Cell Cardiol 44: 927-937, 2008.
23. Julia P, Young HH, Buckberg GD, Kofsky ER, Bugyi HI. Studies of myocardial protection in the immature heart. IV. Improved tolerance of immature myocardium to hypoxia and ischemia by intravenous metabolic support. J Thorac Cardiovasc Surg 101: 23-32, 1991.
24. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucl Acids Res 28: 27-30, 2000.
25. Kisker C, Schindelin H, Pacheco A, Wehbi WA, Garrett RM, Rajagopalan KV, Enemark JH, Rees DC. Molecular basis of sulfite oxidase deficiency from the structure of sulfite oxidase. Cell 91: 973-983, 1997.
26. Kisker C, Schindelin H, Rees DC. Molybdenum-cofactor-containing enzymes: structure and mechanism. Ann Rev Biochem 66: 233-267, 1997.
27. Konstantinov IE, Coles JG, Boscarino C, Takahashi M, Goncalves J, Ritter J, Van Arsdell GS. Gene expression profiles in children undergoing cardiac surgery for right heart obstructive lesions. J Thorac Cardiovasc Surg 127: 746-754, 2004.
28. Kundu TK, Hille R, Velayutham M, Zweier JL. Characterization of superoxide production from aldehyde oxidase: an important source of oxidants in biological tissues. Arch Biochem Biophys 460: 113-121, 2007.
29. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312: 159-163, 1985.
30. Mehlhorn U, Krahwinkel A, Geissler HJ, LaRosee K, Fischer UM, Klass O, Suedkamp M, Hekmat K, Tossios P, Bloch W. Nitrotyrosine and 8-isoprostane formation indicate free radical-mediated injury in hearts of patients subjected to cardioplegia. J Thorac Cardiovasc Surg 125: 178-183, 2003.
31. Modi P, Imura H, Caputo M, Pawade A, Parry A, Angelini GD, Suleiman MS. Cardiopulmonary bypass-induced myocardial reoxygenation injury in pediatric patients with cyanosis. J Thorac Cardiovasc Surg 124: 1035-1036, 2002.
32. Modi P, Suleiman MS, Reeves B, Pawade A, Parry AJ, Angelini GD, Caputo M. Myocardial metabolic changes during pediatric cardiac surgery: a randomized study of 3 cardioplegic techniques. J Thorac Cardiovasc Surg 128: 67-75, 2004.
33. Morita K, Ihnken K, Buckberg GD, Sherman MP, Young HH. Studies of hypoxemic/reoxygenation injury: without aortic clamping. IX. Importance of avoiding perioperative hyperoxemia in the setting of previous cyanosis. J Thorac Cardiovasc Surg 110: 1235-1244, 1995.
34. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucl Acids Res 29: e45, 2001.
35. Reilly MP, Delanty N, Roy L, Rokach J, Callaghan PO, Crean P, Lawson JA, FitzGerald GA. Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation 96: 3314-3320, 1997.
36. Ruel M, Bianchi C, Khan TA, Xu S, Liddicoat JR, Voisine P, Araujo E, Lyon H, Kohane IS, Libermann TA, Sellke FW. Gene expression profile after cardiopulmonary bypass and cardioplegic arrest. J Thorac Cardiovasc Surg 126: 1521-1530, 2003.
37. Sehl PD, Tai JT, Hillan KJ, Brown LA, Goddard A, Yang R, Jin H, Lowe DG. Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury. Circulation 101: 1990-1999, 2000.
38. Teoh KH, Mickle DA, Weisel RD, Li RK, Tumiati LC, Coles JG, Williams WG. Effect of oxygen tension and cardiovascular operations on the myocardial antioxidant enzyme activities in patients with tetralogy of Fallot and aorta-coronary bypass. J Thorac Cardiovasc Surg 104: 159- 164, 1992.
39. Voisine P, Ruel M, Khan TA, Bianchi C, Xu SH, Kohane I, Libermann TA, Otu H, Saltiel AR, Sellke FW. Differences in gene expression profiles of diabetic and nondiabetic patients undergoing cardiopulmonary bypass and cardioplegic arrest. Circulation 110: II280-II286, 2004.